| GSK TRC 112765 |
| Other |
| Phase I/II Dose Finding Study of Eltrombopag in Patients with Solid Tumors Receiving Gemzar or Cisplatin or Gemzar plus Carboplatin |
| GSK TRC 112765 |
| Other |
| Phase I/II Dose Finding Study of Eltrombopag in Patients with Solid Tumors Receiving Gemzar or Cisplatin or Gemzar plus Carboplatin |